Advisory: Alert incorrectly tagged to Tempest Therapeutics withdrawn
05/12/2023 24:39
Dec 4 (Reuters) - Alerts on Tempest announcing leadership transition are being withdrawn as they were incorrectly tagged to Tempest Therapeutics Inc TPST.O , an unrelated entity, and have been withdrawn. There will be no substitute. STORY_NUMBER: TUA7ZCMWS STORY_DATE: 05/12/2023 STORY_TIME: 12:17:26 ((Bangalore.newsroom@thomsonreuters.com))
Recent news on Tempest Therapeutics
See all newsBrief: Tempest Therapeutics - Justin Trojanowski To Resign As Principal Financial Officer And Principal Accounting Officer Effective Sept 1 - SEC Filing
Tempest Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tempest Therapeutics - Enters $50 Million Common Stock Purchase Agreement With Lincoln Park
Tempest Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
Brief: Tempest Announces Development Collaboration With Senlang Biotechnology For TPST-4003, A CD7-Targeted Next-Generation In Vivo CAR-T